These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 8218755)
21. Acute treatment of reflux oesophagitis: a multicentre study to compare 150 mg ranitidine twice daily with 300 mg ranitidine at bedtime. Halvorsen L; Lee FI; Wesdorp IC; Johnson NJ; Mills JG; Wood JR Aliment Pharmacol Ther; 1989 Apr; 3(2):171-81. PubMed ID: 2491468 [TBL] [Abstract][Full Text] [Related]
22. A comparative study of cisapride and ranitidine at controlling oesophageal acid exposure in erosive oesophagitis. Pouderoux P; Kahrilas PJ Aliment Pharmacol Ther; 1995 Dec; 9(6):661-6. PubMed ID: 8824654 [TBL] [Abstract][Full Text] [Related]
23. Cisapride in the treatment of gastro-oesophageal reflux disease. Robertson CS; Evans DF; Ledingham SJ; Atkinson M Aliment Pharmacol Ther; 1993 Apr; 7(2):181-90. PubMed ID: 8485271 [TBL] [Abstract][Full Text] [Related]
24. The effect of cisapride in maintaining symptomatic remission in patients with gastro-oesophageal reflux disease. Hatlebakk JG; Johnsson F; Vilien M; Carling L; Wetterhus S; Thøgersen T Scand J Gastroenterol; 1997 Nov; 32(11):1100-6. PubMed ID: 9399390 [TBL] [Abstract][Full Text] [Related]
25. Ranitidine 300 mg twice daily and 150 mg four-times daily are effective in healing erosive oesophagitis. Silver MT; Murdock RH; Morrill BB; Sue SO Aliment Pharmacol Ther; 1996 Jun; 10(3):373-80. PubMed ID: 8791966 [TBL] [Abstract][Full Text] [Related]
26. The effect of combined therapy with ranitidine and pirenzepine in the treatment of reflux oesophagitis. Londong W; Phillips J; Johnson NJ; Wood JR Aliment Pharmacol Ther; 1992 Oct; 6(5):609-18. PubMed ID: 1420752 [TBL] [Abstract][Full Text] [Related]
27. Combined therapy with cisapride and cimetidine in severe reflux oesophagitis: a double blind controlled trial. Galmiche JP; Brandstätter G; Evreux M; Hentschel E; Kerstan E; Kratochvil P; Reichel W; Schütze K; Soule JC; Vitaux J Gut; 1988 May; 29(5):675-81. PubMed ID: 3294124 [TBL] [Abstract][Full Text] [Related]
29. The effect of cisapride and ranitidine as monotherapies and in combination in the treatment of uncomplicated gastric ulceration. Stubberöd A; Glise H; Hallerbäck B; Solhaug JH Scand J Gastroenterol; 1995 Feb; 30(2):106-10. PubMed ID: 7732330 [TBL] [Abstract][Full Text] [Related]
30. Comparison of omeprazole and histamine H2-receptor antagonists in the treatment of elderly and young patients with reflux oesophagitis. James OF; Parry-Billings KS Age Ageing; 1994 Mar; 23(2):121-6. PubMed ID: 8023719 [TBL] [Abstract][Full Text] [Related]
31. Ranitidine in reflux oesophagitis. A double-blind placebo-controlled study. Hine KR; Holmes GK; Melikian V; Lucey M; Fairclough PD Digestion; 1984; 29(2):119-23. PubMed ID: 6329862 [TBL] [Abstract][Full Text] [Related]
32. Comparison of Algicon and ranitidine in the therapy of reflux oesophagitis: preliminary results. Pace F; Sangaletti O; Bianchi Porro G Br J Clin Pract Suppl; 1989 Feb; 66():59-60; discussion 61-4. PubMed ID: 2511924 [No Abstract] [Full Text] [Related]
34. Cisapride for gastro-oesophageal reflux and peptic oesophagitis. Cucchiara S; Staiano A; Capozzi C; Di Lorenzo C; Boccieri A; Auricchio S Arch Dis Child; 1987 May; 62(5):454-7. PubMed ID: 3300570 [TBL] [Abstract][Full Text] [Related]
35. Short and long-term effect of two different dosages of ranitidine in the therapy of reflux oesophagitis. Pace F; Sangaletti O; Bianchi Porro G Ital J Gastroenterol; 1990 Feb; 22(1):28-32. PubMed ID: 2131925 [TBL] [Abstract][Full Text] [Related]
36. Healing of grade-II and III oesophagitis through motility stimulation with cisapride. Lepoutre L; Van der Spek P; Vanderlinden I; Bollen J; Laukens P Digestion; 1990; 45(2):109-14. PubMed ID: 2190850 [TBL] [Abstract][Full Text] [Related]
37. Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis. Klinkenberg-Knol EC; Jansen JM; Festen HP; Meuwissen SG; Lamers CB Lancet; 1987 Feb; 1(8529):349-51. PubMed ID: 2880161 [TBL] [Abstract][Full Text] [Related]
38. Lansoprazole versus ranitidine for the treatment of reflux oesophagitis. UK Lansoprazole Clinical Research Group. Bardhan KD; Hawkey CJ; Long RG; Morgan AG; Wormsley KG; Moules IK; Brocklebank D Aliment Pharmacol Ther; 1995 Apr; 9(2):145-51. PubMed ID: 7605854 [TBL] [Abstract][Full Text] [Related]
39. Omeprazole or high-dose ranitidine in the treatment of patients with reflux oesophagitis not responding to 'standard doses' of H2-receptor antagonists. Lundell L; Backman L; Ekström P; Enander LH; Fausa O; Lind T; Lönroth H; Sandmark S; Sandzén B; Unge P Aliment Pharmacol Ther; 1990 Apr; 4(2):145-55. PubMed ID: 1983321 [TBL] [Abstract][Full Text] [Related]
40. Cisapride and cimetidine in the treatment of erosive esophagitis. Maleev A; Mendizova A; Popov P; Vlahov V; Dimitrov B; Mihova A; Crowe J; Silveira J; Thomson A; Routhier G Hepatogastroenterology; 1990 Aug; 37(4):403-7. PubMed ID: 2210608 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]